Apan beta amyloid 5-amino acid inhibitor: Started Phase I testing

Praecis Pharmaceuticals Inc. (PRCS), Cambridge, Mass.

Read the full 68 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE